Production and antiproliferative activity of liposomes containing the antitumour drug chromomycin A3

J Microencapsul. 1998 Jul-Aug;15(4):465-72. doi: 10.3109/02652049809006873.

Abstract

In the present paper the production and characterization of liposomes are described as a specialized drug delivery system for chromomycin. Liposomes were prepared by the reverse phase evaporation technique followed by extrusion through polycarbonate filters; afterwards the vesicles were characterized in terms of dimensions, morphology and encapsulation efficacy. The aim of this work was to produce a drug delivery system able to reduce the toxicity problems related to the administration of this drug. The analysis of the in vitro antiproliferative activity on cultured human leukemic K562 cells demonstrated that ionic and neutral liposomes containing chromomycin are 1.5 and 7-fold more effective respectively as compared to the free drug. Based on these results and taking into account the increased solubility of the drug in this system, liposomes could represent a promising drug delivery system for use in the experimental therapy using chromomycin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoglycosides
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Cell Division / drug effects
  • Chemical Phenomena
  • Chemistry, Physical
  • Chromatography, High Pressure Liquid
  • Chromomycin A3 / administration & dosage*
  • Chromomycin A3 / chemistry
  • Chromomycin A3 / pharmacology
  • Drug Carriers
  • Humans
  • Liposomes
  • Particle Size
  • Tumor Cells, Cultured

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Drug Carriers
  • Liposomes
  • Chromomycin A3